Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Chullikana A"'
Autor:
Chullikana, Anoop, Majumdar, Anish Sen, Gottipamula, Sanjay, Krishnamurthy, Sagar, Kumar, A. Sreenivas, Prakash, V.S., Gupta, Pawan Kumar
Publikováno v:
In Cytotherapy March 2015 17(3):250-261
Autor:
Thomas C, Blevins, Yaron, Raiter, Bin, Sun, Charles, Donnelly, Roxann, Shapiro, Anoop, Chullikana, Anita, Rao, Laxmikant, Vashishta, Gopinath, Ranganna, Abhijit, Barve
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 36(6)
MYL-1601D is a proposed biosimilar of originator insulin aspart, NovologThis study assessed the immunogenicity, efficacy, and safety of MYL-1601D with Ref-InsAsp-US in patients with type 1 diabetes mellitus (T1D).This was a 24-week, open-label, rando
Autor:
Pawan Kumar Gupta, Anoop Chullikana, Raviraja NS, Uday kumar K, Shivashankar P, Pachaiyappan Viswanathan, Mithun Chandrashekar, Charan Thej, Prasanth KV, Jijy Abraham, Anish Sen Majumdar
Publikováno v:
International Journal of Regenerative Medicine. :1-19
Background: Alcoholic liver cirrhosis is an end-stage alcoholic liver disease with a poor prognosis. The definitive treatment of alcoholic liver cirrhosis is orthotopic liver transplantation, which is expensive, requires long-term immunosuppression a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ulrike, Hövelmann, Yaron, Raiter, Anoop, Chullikana, Mark, Liu, Charles, Donnelly, Tracey, Lawrence, Nilanjan, Sengupta, Gopu, Cl, Gopinath, Ranganna, Abhijit, Barve
Publikováno v:
Diabetes, obesitymetabolism. 23(12)
To evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence (BE) of MYL-1601D biosimilar with originator, NovoLog (Ref-InsAsp-US), and NovoRapid (Ref-InsAsp-EU).This was a double-blind, randomized, crossover study that enrolled 71 he
Autor:
null Ulrike Hövelmann, null Yaron Raiter, null Anoop Chullikana, null Mark Liu, null Charles Donnelly, null Tracey Lawrence, null Nilanjan Sengupta, null Gopu CL, null Gopinath Ranganna, null Abhijit Barve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62a0e45e048e51435d8b81b093cc3286
https://doi.org/10.1111/dom.14519/v2/response1
https://doi.org/10.1111/dom.14519/v2/response1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ulrike Hövelmann, Anoop Chullikana, Charles Donnelly, Yaron Raiter, Tracey E. Lawrence, Mark Liu, C L Gopu, Nilanjan Sengupta, Gopinath Ranganna, Abhijit Barve
Publikováno v:
Diabetes. 70
Autor:
Gopinath Ranganna, Yaron Raiter, Roxann Shapiro, Bin Sun, Thomas Blevins, Charles Donnelly, Laxmikant Vashishta, Anoop Chullikana, Anita U. Rao, Abhijit Barve
Publikováno v:
Diabetes. 70
MYL-1601D is a rapid-acting human insulin analog produced by recombinant DNA technology utilizing Pichia pastoris yeast. This was a randomized, multicenter, open-label, parallel-group study to compare the safety and efficacy of MYL-1601D with NovoLog
Publikováno v:
Diabetes. 70